Conmed Corp
F:EC8
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Conmed Corp
F:EC8
|
US |
|
A
|
Allianz SE
XMUN:ALV
|
DE |
|
I
|
Intesa Sanpaolo SpA
XMUN:IES
|
IT |
|
B
|
Basf Se
XHAM:BAS
|
DE |
|
R
|
RTL Group SA
DUS:RRTL
|
LU |
|
C
|
Cooper-Standard Holdings Inc
F:C31
|
US |
|
R
|
Range Resources Corp
F:RAX
|
US |
|
S
|
Schumag AG
XHAM:SCM
|
DE |
|
A
|
Adecoagro SA
F:ACD
|
LU |
|
Atoss Software AG
F:AOF
|
DE |
|
E
|
Estee Lauder Companies Inc
XMUN:ELAA
|
US |
|
J
|
Jefferies Financial Group Inc
F:LN3
|
US |
|
I
|
Ionis Pharmaceuticals Inc
XMUN:ISI
|
US |
Wall St Price Targets
EC8 Price Targets Summary
Conmed Corp
According to Wall Street analysts, the average 1-year price target for EC8 is 50.14 EUR with a low forecast of 45.56 EUR and a high forecast of 63.15 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is EC8's stock price target?
Price Target
50.14
EUR
According to Wall Street analysts, the average 1-year price target for EC8 is 50.14 EUR with a low forecast of 45.56 EUR and a high forecast of 63.15 EUR.
What is the Revenue forecast for Conmed Corp?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 3 years is 4%.
What is the Operating Income forecast for Conmed Corp?
Projected CAGR
31%
Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 3 years is 31%.
What is the Net Income forecast for Conmed Corp?
Projected CAGR
53%
Over the last 13 years, the compound annual growth rate for Net Income has been 1%. The projected CAGR for the next 3 years is 53%.
